Literature DB >> 9773780

Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease.

E Ritz1, U Benck, E Franek, C Keller, M Seyfarth, J Clorius.   

Abstract

Patients with renal disease who smoke have a poor renal functional prognosis, but the mechanisms involved have not been explored. In this controlled study, the effects of smoking and sham smoking were compared in 15 healthy normotensive volunteers. All were occasional smokers and abstained from smoking for 48 h as documented by urinary cotinine measurements. These data were compared with those of seven patients with biopsy-confirmed IgA glomerulonephritis, also occasional smokers. Renal clearance examinations were obtained after hydration in the supine position before and while smoking two cigarettes or sham cigarettes in random order on 2 consecutive days. GFR and effective renal plasma flow were determined using In111-diethylenetriamine penta-acetic acid and 131I-hippurate with a dual tracer infusion clearance technique. In an ancillary study with six volunteers, the effect of smoking was compared with the effect of nicotine-containing chewing gum. In healthy volunteers, sham smoking caused a minor but significant increase of mean arterial pressure (MAP) and GFR with no significant change of effective renal plasma flow, filtration fraction (FF), or renovascular resistance. Smoking caused a significant and more marked increase of MAP (from baseline 92.8+/-8.98 to 105+/-7.78 mmHg) and heart rate (from 61.7+/-7.52 to 86.4+/-9.87 min(-1)), accompanied by a significant increase in arginine vasopressin (from 1.27+/-0.72 to 19.9+/-27.2 pg/ml) and epinephrine (from 37+/-13 to 140+/-129 pg/ml). During smoking, GFR decreased in all but one volunteer (from 120+/-17.7 to 102+/-19.3 ml/min per 1.73 m2), and this was accompanied by a significant decrease of FF (from 21.3+/-4.24 to 17.4+/-3.41%) and an increase in renovascular resistance (from 97.6+/-27.2 to 108+/-30.4 mmHg x min/ml per 1.73 m2). These findings were reproduced with nicotine-containing chewing gum. In contrast, when patients with IgA glomerulonephritis smoked, a similar increment in MAP was noted, the changes of FF were not uniform, and a small but consistent increase of urinary albumin/creatinine ratio was observed. An additional 20 volunteers were subjected to the smoking arm of the study for statistical evaluation of the GFR change in patients. The difference between the change of GFR between all volunteers (n = 35) and patients (n = 7) was significant (P < 0.005). It is concluded that the known effects of smoking and nicotine on the sympathetic nervous system and on systemic hemodynamics are accompanied by significant acute changes in renal hemodynamics and albuminuria. These findings are of interest because of the known effects of smoking on progression of renal disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773780     DOI: 10.1681/ASN.V9101798

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.

Authors:  Jula K Inrig; Huiman X Barnhart; Donal Reddan; Uptal D Patel; Shelly Sapp; Robert M Califf; Ajay K Singh; Lynda A Szczech
Journal:  Am J Kidney Dis       Date:  2012-04-25       Impact factor: 8.860

2.  Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men.

Authors:  Isseki Maeda; Tomoshige Hayashi; Kyoko Kogawa Sato; Hideo Koh; Nobuko Harita; Yoshiko Nakamura; Ginji Endo; Hiroshi Kambe; Kanji Fukuda
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

3.  Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases.

Authors:  Jun Wu; Shengqiang Yu; Vickram Tejwani; Michael Mao; Angela K Muriithi; Chaoyang Ye; Xuezhi Zhao; Hongchen Gu; Changlin Mei; Qi Qian
Journal:  Clin Exp Nephrol       Date:  2014-01-10       Impact factor: 2.801

4.  Different association of cigarette smoking with GFR estimated from serum creatinine and that from serum cystatin C in the general population.

Authors:  Yuichi Yamada; Yuka Noborisaka; Masao Ishizaki; Michiko Yamazaki; Ryumon Honda; Hitoshi Yokoyama; Tatsuyuki Kakuma
Journal:  Clin Exp Nephrol       Date:  2014-11-19       Impact factor: 2.801

5.  The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan.

Authors:  Yuka Noborisaka; Masao Ishizaki; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2012-05-24       Impact factor: 3.674

6.  The association of alcohol and smoking with CKD in a Japanese nationwide cross-sectional survey.

Authors:  Ayako Matsumoto; Yasuyuki Nagasawa; Ryohei Yamamoto; Maki Shinzawa; Yukiko Hasuike; Takahiro Kuragano; Yoshitaka Isaka; Takeshi Nakanishi; Kunitoshi Iseki; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Shouichi Fujimoto; Koichi Asahi; Toshiki Moriyama; Tsuyoshi Watanabe
Journal:  Hypertens Res       Date:  2017-03-09       Impact factor: 3.872

7.  Estimated GFR associates with cardiovascular risk factors independently of measured GFR.

Authors:  Ulla Dorte Mathisen; Toralf Melsom; Ole C Ingebretsen; Trond Jenssen; Inger Njølstad; Marit D Solbu; Ingrid Toft; Bjørn O Eriksen
Journal:  J Am Soc Nephrol       Date:  2011-03-31       Impact factor: 10.121

8.  Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc.

Authors:  Istvan Arany; Jeb Clark; Dustin K Reed; Luis A Juncos
Journal:  Nephrol Dial Transplant       Date:  2013-01-16       Impact factor: 5.992

9.  Association of smoking with prevalence of common diseases and metabolic abnormalities in community-dwelling Japanese individuals.

Authors:  Chikara Ueyama; Hideki Horibe; Yuichiro Yamase; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2017-09-27

Review 10.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.